FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/054761 [Registered on: 05/07/2023] Trial Registered Prospectively
Last Modified On: 04/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Curative]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study to treat hyperpigmentation by using Chinchadi lepa  
Scientific Title of Study   A Randomized open labelled controlled clinical study to evaluate the efficacy of Chinchadi lepa in the management of Vyanga with special reference to Melasma. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhavana H N 
Designation  PG SCHOLAR 
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  #114,1ST CROSS,NEAR NARAYANA E TECHNO SCHOOL,BALAJI LAYOUT, MALLATHAHALLI BANGALORE-560056
Department of Dravyaguna, Sri Sri College Of Ayurvedic Science and Research, Udayapura post, Bengaluru- 560082
Bangalore
KARNATAKA
560056
India 
Phone  09108129795  
Fax    
Email  bhavanaudupa948@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr MAHESH C D 
Designation  Professor 
Affiliation  Sri Sri College of Ayurvedic Science and Research Bengaluru 
Address  Sri Sri College Of Ayurvedic Science and Research Hospital, Department of Dravyaguna OPD, Room no 105,21st km, Kanakapura road, Udayapura post, Bengaluru

Bangalore
KARNATAKA
560082
India 
Phone  9986303884  
Fax    
Email  drmaheshcd@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Bhavana H N 
Designation  PG SCHOLAR 
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  #114,1ST CROSS,NEAR NARAYANA E TECHNO SCHOOL,BALAJI LAYOUT, MALLATHAHALLI BANGALORE-560056
Department of Dravyaguna, Sri Sri College Of Ayurvedic Science and Research, Udayapura post, Bengaluru- 560082

KARNATAKA
560056
India 
Phone  09108129795  
Fax    
Email  bhavanaudupa948@gmail.com  
 
Source of Monetary or Material Support  
Sri Sri College of Ayurvedic Science and Research 
 
Primary Sponsor  
Name  SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH 
Address  SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH, KANAKAPURA ROAD, UDAYAPURA POST, BENGALURU-560082. 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhavana H N  Sri Sri College of Ayurvedic Science and Research Hospital, Kanakapura road, Bengaluru.   Survey No.269/270, B.M. Kaval, Udayapura P.O., 21 KM, Kanakapura Rd, Bengaluru, Karnataka 560082, Bengaluru
Bangalore
KARNATAKA 
9108129795

bhavanaudupa948@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Sri Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L811||Chloasma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Chinchadi Lepa  The subjects will be asked to wash the face and dry it completely with a clean cloth. Chinchadi Lepa will be given and asked to apply quantity sufficient of lepa as thin layer over the affected area and massage it on outward and upward stroke until it is absorbed. Duration- Once a day. 
Comparator Agent  Kunkumadi Lepa  The subjects will be asked to wash the face and dry it completely with a clean cloth. Kunkumadi Lepa will be given and asked to apply quantity suffient of Lepa as a thin layer over the affected area and massage it in outward and upward stroke until it is absorbed Duration- Once a day 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Subjects of either gender with the age group between 21-60 years.
Subjects fulfilling the diagnostic criteria of Vyanga with special reference to Melasma will be randomly selected, irrespective of their religion, occupation and socio-economic status. 
 
ExclusionCriteria 
Details  Female on oral contraceptive pills, pregnant women and lactating women.
Subjects who are on any hormonal therapy.
Subjects who are known hyperpigmentation since birth.
Subjects who are known inflammatory pigmentation.
Subjects who are known malignant melanoma.
Any other condition interfering with the course of the treatment. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction of hyperpigmentation  One year. 
 
Secondary Outcome  
Outcome  TimePoints 
Complexion improvement  One year 
 
Target Sample Size   Total Sample Size="15000"
Sample Size from India="15" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   17/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Randomized Parallel group open- labelled.controlled clinical study.
 FeaturesGroup A Group B 
 Sample size 1515 
 InterventionKunkumadi Lepa Chinchadi Lepa
 DosageQuantity sufficient Quantity sufficient 
 Time of administrationMorning Morning 
 Trial Period30 days 30 days 
 Mode of administrationExternal application External application
 Total Weight50g 50g 
 Assessment0th, 15th, 30th Day 0th, 15th, 30th Day 
 Drug free follow up45th day 45th day 
 
Close